Clorox Company (The) stocks have been trading up by 5.03 percent following strong earnings and improved margin guidance.
Weekly Update Jun 01 – Jun 05, 2026: On Friday, June 05, 2026 Clorox Company (The) stock [NYSE: CLX] is trending up by 5.03%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Consumer Staples industry expert:
Analyst sentiment – neutral
Clorox holds a solid but no longer dominant growth position in Household Products, with flat revenue and slightly negative three- and five-year CAGRs underscoring category maturity and share pressure. Profitability is respectable (gross margin 43.9%, EBIT margin 16.1%, consolidated net margin ~11%) and ROA/ROIC remain healthy, but the balance sheet is stretched: negative equity, long-term debt to capital above 1.0, current ratio 0.8, and operating cash flow negative this quarter, masked by short-term debt-funded cash build.
Technically, the weekly tape shows a narrow consolidation band between roughly 88.5 and 90 ahead of the sharp spike to 94.14, signaling a short-term upside break after a base. With closes clustered around 89–90 before the breakout, that 89.50–90.00 zone is a clear pivot and should act as first support. Assuming average to above-average volume on the breakout, an actionable level is to buy on pullbacks toward 90 with a tight stop around 88.25.
Near term, the CEO transition is the key overhang; while orderly, it raises execution risk versus Consumer Staples and Household & Personal peers that enjoy more stable leadership and better top-line momentum. Mixed Q3 (flat sales, Lifestyle softness, margin compression) justifies CFRA’s target cut and a valuation discount despite a seemingly modest 15.7x P/E and elevated 5.5% dividend yield. Base case: Neutral, with tactical trading range of $85 support to $105 resistance; strategic investors should wait for leverage reduction and clearer successor visibility.
Quick Financial Overview
Clorox Company (The) shows a stock that has firmed up in the very near term. The weekly tape has CLX grinding from the high $80s to a close near $94, a roughly 5% push that tells you dip buyers have stepped in despite mixed headlines. Intraday, the 5‑minute chart shows a steady intraday uptrend, with higher lows from around $91 at the open to a close at $94.14, suggesting persistent demand rather than one headline spike.
On fundamentals, CLX generated about $7.10B in revenue over the trailing period with a gross margin near 43.9% and EBIT margin around 16.1%. Those are solid profitability levels for a consumer staples name, but the 3‑ and 5‑year revenue growth rates are slightly negative, so this is more of a margin and cash‑flow story than a top‑line growth play. Q3 revenue of $1.67B produced operating income of $289M and net income of $187M, which aligns with CFRA’s “mixed” Q3 language.
Balance sheet and cash‑flow data highlight why the market stays cautious. CLX carries meaningful leverage, with long‑term debt around $2.81B and commercial paper over $1.59B, and a current ratio of 0.8 signals a tight liquidity profile. The latest quarter showed negative operating cash flow of roughly -$122M and negative free cash flow of about -$165M, even as management paid $150M in dividends and leaned on $1.28B of short‑term debt issuance to boost cash. The trailing dividend yield near 5.5% looks attractive, but traders must recognize it sits on a leveraged, capital‑intensive base.
More Breaking News
- KVUE Stock Holds Steady As Earnings Beat Backs Kimberly-Clark Deal
- LQDA Stock Extends Run As Analysts Hike Price Targets
- NCLH Stock Grinds Higher As Wall Street Backs Turnaround
- SNAP Stock Climbs As S&P Upgrade Backs Turnaround Story
Conclusion
Leadership Transition, Margin Pressure, And Trading Levels
For traders, CLX is sitting at an interesting balance point between solid franchise strength and visible headwinds. The planned CEO transition, with Linda Rendle remaining in place until a successor is named and then shifting to an advisory role, softens governance risk but does not remove it. Markets often wait to hear a new leader’s strategy before rerating a name like Clorox Company (The), especially when earnings growth is muted.
On the earnings side, CFRA’s move to cut the 12‑month target to $112 and trim outer‑year EPS estimates says the Street is not ready to pay up for this tape yet. Flat sales, margin compression, and Lifestyle weakness line up with the financials: good profitability on paper, but pressure on cash generation and a levered balance sheet. At the same time, the new Clorox Healthcare wipe platforms and ongoing Glad brand pushes show that CLX still has levers in premium and everyday categories.
From a trading perspective, the recent push into the mid‑$90s after basing in the high $80s gives you a clear short‑term range to work with. Upside reactions may fade as price approaches any heavy overhead supply near prior target zones, while dips back toward the high $80s could attract swing buyers if news stays stable. Upcoming conference commentary on margins, restructuring, and the CEO search will be key catalysts for CLX’s next move. As I tell my students, “You do not get paid for having an opinion on a company; you get paid for reading the tape, respecting the risk, and trading the levels the market is actually giving you.” That means focusing less on prediction and more on preparation and execution. As millionaire penny stock trader and teacher Tim Sykes says, “Preparation plus patience leads to big profits.”
This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.
Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:
- Penny Stocks Trading Guide
- Best Penny Stocks Under $1 to Buy Today
- Top 8 Penny Stocks to Watch on Robinhood
Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:
Leave a reply